Ovarian tumors of low malignant potential.

被引：7

作者：

Trimble E.L. ^{[1
,2
]}

Trimble C.L. ^{[2
]}

机构：

[1] National Cancer Institute, Bethesda, MD 20892-7436, 6130 Executive Boulevard, Suite 741

[2] The Johns Hopkins Hospital, Baltimore, MD 21287

来源：

Current Treatment Options in Oncology | 2001年 / 2卷 / 2期

关键词：

Epithelial Ovarian Cancer; Ovarian Tumor; Borderline Tumor; Epithelial Ovarian Carcinoma; Pseudomyxoma Peritonei;

D O I：

10.1007/s11864-001-0052-2

中图分类号：

学科分类号：

摘要：

Ovarian tumors of low malignant potential (LMP) differ from epithelial ovarian carcinoma in etiology, molecular biology, and prognosis. LMP tumors are not precursor lesions to ovarian carcinoma. Treatment is primarily surgical. Women found to have an ovarian tumor of LMP should undergo removal of the involved adnexa; surgical staging; and cytoreductive surgery. Women in the reproductive years should be given the option of conservative surgery, preserving the contralateral adnexa and uterus. There is no proven benefit to adjuvant chemotherapy or radiotherapy after primary surgery. In most cases, the diagnosis of an ovarian tumor of LMP conveys good prognosis, with excellent long-term survival.

引用

页码：103 / 108

页数：5

共 32 条

[11]

Harris R, Whittemore AS, Itnyre J, Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group, Am J Epidemiol, 136, pp. 1204-1211, (1992)

[12]

McCluskey LL, Dubeau LL, Biology of ovarian cancer, Curr Opin Oncol, 9, pp. 465-470, (1997)

[13]

Lu KH, Bell DA, Welch WR, Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors, Cancer Res, 58, pp. 2328-2330, (1998)

[14]

Caduff RG, Svoboda-Newman SM, Ferguson AW, Comparison of mutations of Ki-ras and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors, Am J Surg Pathol, 23, pp. 323-328, (1999)

[15]

Evans MR, McDicken IW, Herrington CS, Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumors, J Pathol, 189, pp. 53-59, (1999)

[16]

Bjorge T, Engeland A, Hansen S, Prognosis of patients with ovarian cancer and borderline tumors diagnosed in Norway between 1954 and 1993, Int J Cancer, 75, pp. 663-670, (1998)

[17]

Seidman JD, Kurman RJ, Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators, Hum Pathol, 31, pp. 539-557, (2000)

[18]

Yeo EL, Yu KM, Poddar MC, The accuracy of intraoperative frozen section in the diagnosis of ovarian tumors, J Obstet Gynaecol Res, 24, pp. 189-915, (1998)

[19]

Houck K, Nikrui N, Duska L, Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis, Obstet Gynecol, 95, pp. 839-843, (2000)

[20]

Kayicioglu F, Pata O, Cengiz S, Accuracy of frozen section diagnosis in borderline ovarian malignancy, Gynecol Obstet Invest, 49, pp. 187-189, (2000)

← 1 2 3 4 →